Bisphenol F diglycidyl ether
Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen
2095-03-6c1cc(OCC2CO2)ccc1Cc1ccc(OCC2CO2)cc1XUCHXOAWJMEFLF-UHFFFAOYSA-N2095-03-6、39817-09-9Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.
This chemical does not meet GHS hazard criteria for 4.5% (3 of 66) of reports.
Warning
H315 (95.5%): Causes skin irritation [Warning Skin corrosion/irritation];H317 (95.5%): May cause an allergic skin reaction [Warning Sensitization, Skin];H319 (75.8%): Causes serious eye irritation [Warning Serious eye damage/eye irritation];H335 (68.2%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation];H400 (68.2%): Very toxic to aquatic life [Warning Hazardous to the aquatic environment, acute hazard];H410 (68.2%): Very toxic to aquatic life with long lasting effects [Warning Hazardous to the aquatic environment, long-term hazard];H411 (27.3%): Toxic to aquatic life with long lasting effects [Hazardous to the aquatic environment, long-term hazard]
P261, P264, P264+P265, P271, P272, P273, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P333+P317, P337+P317, P362+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 66 reports by companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.;Reported as not meeting GHS hazard criteria per 3 of 66 reports by companies.;There are 5 notifications provided by 63 of 66 reports by companies with hazard statement code(s).;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Chemical: Oxirane, 2,2'-[methylenebis(phenyleneoxymethylene)]bis-
Hazard Traits - Endocrine Toxicity;Authoritative List - CECBP - Priority Chemicals;Report - if used as a fragrance or flavor ingredient
Council Directive (EEC) No 109/1989 (Repealed by Reg. EC No 1935/2004 (amended))
VerwendenBisphenol F Diglycidyl Ether is an novalac glycidyl ether (NOGE). Bisphenol F Diglycidyl Ether is found in resin used as coatings for food cans. Bisphenol F Diglycidyl Ether is a toxic conatminant wit h strict limitations on the amount allowed in food products.
Wird geladen…
DTXSID4044872CHEMBL3182674CHEBI:142451Oxirane, 2,2'-[methylenebis(4,1-phenyleneoxymethylene)]bis-: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Oxirane, 2,2'-[methylenebis(phenyleneoxymethylene)]bis-: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Skin Irrit. 2 (95.5%);Skin Sens. 1 (95.5%);Eye Irrit. 2 (75.8%);STOT SE 3 (68.2%);Aquatic Acute 1 (68.2%);Aquatic Chronic 1 (68.2%);Aquatic Chronic 2 (27.3%)
Skin Irrit. 2 (100%);Skin Sens. 1 (100%);Eye Irrit. 2 (100%);Aquatic Chronic 2 (100%)
EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.;SKIN: IMMEDIATELY flood affected skin with water while removing and isolating all contaminated clothing. Gently wash all affected skin areas thoroughly with soap and water. If symptoms such as redness or irritation develop, IMMEDIATELY call a physician and be prepared to transport the victim to a hospital for treatment.;INHALATION: IMMEDIATELY leave the contaminated area; take deep breaths of fresh air. If symptoms (such as wheezing, coughing, shortness of breath, or burning in the mouth, throat, or chest) develop, call a physician and be prepared to transport the victim to a hospital. Provide proper respiratory protection to rescuers entering an unknown atmosphere. Whenever possible, Self-Contained Breathing Apparatus (SCBA) should be used; if not available, use a level of protection greater than or equal to that advised under Protective Clothing.;INGESTION: DO NOT INDUCE VOMITING. If the victim is conscious and not convulsing, give 1 or 2 glasses of water to dilute the chemical and IMMEDIATELY call a hospital or poison control center. Be prepared to transport the victim to a hospital if advised by a physician. If the victim is convulsing or unconscious, do not give anything by mouth, ensure that the victim's airway is open and lay the victim on his/her side with the head lower than the body. DO NOT INDUCE VOMITING. IMMEDIATELY transport the victim to a hospital. (NTP, 1992)
RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter. (NTP, 1992)
Chemical: Oxirane, 2,2'-[methylenebis(phenyleneoxymethylene)]bis-
Hazard Traits - Endocrine Toxicity;Authoritative List - CECBP - Priority Chemicals;Report - if used as a fragrance or flavor ingredient
Council Directive (EEC) No 109/1989 (Repealed by Reg. EC No 1935/2004 (amended))
Oxirane, 2,2'-[methylenebis(4,1-phenyleneoxymethylene)]bis-: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Oxirane, 2,2'-[methylenebis(phenyleneoxymethylene)]bis-: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.